MFE:PA:PA-Lyxor UCITS MSCI EMU (EUR)

ETF | Others |

Last Closing

USD 65.21

Change

+0.33 (+0.51)%

Market Cap

USD 0.32B

Volume

127.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-22 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

-0.12 (-0.27%)

USD 60.76B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+6.20 (+1.07%)

USD 13.44B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+4.36 (+1.05%)

USD 12.33B
WRD:PA HSBC MSCI World UCITS ETF

+0.32 (+0.87%)

USD 10.94B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+9.70 (+1.92%)

USD 8.88B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

+0.91 (+0.37%)

USD 8.60B
WLD:PA Lyxor UCITS MSCI World D-EUR

+3.14 (+0.87%)

USD 7.71B
HHH:PA HSBC S&P 500 UCITS ETF

+0.63 (+1.08%)

USD 7.47B
LCWD:PA Multi Units Luxembourg - Lyxor..

+0.16 (+0.84%)

USD 6.81B
S500:PA Amundi S&P 500 ESG UCITS ETF A..

+1.62 (+0.98%)

USD 5.39B

ETFs Containing MFE:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.53% 85% B 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 5.53% 85% B 78% C+
Trailing 12 Months  
Capital Gain 11.91% 46% F 63% D
Dividend Return 3.00% 54% F 48% F
Total Return 14.91% 53% F 67% D+
Trailing 5 Years  
Capital Gain 27.41% 48% F 64% D
Dividend Return 13.97% 72% C 57% F
Total Return 41.38% 59% D- 68% D+
Average Annual (5 Year Horizon)  
Capital Gain 10.04% 59% D- 63% D
Dividend Return 12.38% 67% D+ 83% B
Total Return 2.35% 64% D 56% F
Risk Return Profile  
Volatility (Standard Deviation) 15.15% 37% F 82% B
Risk Adjusted Return 81.75% 61% D- 87% B+
Market Capitalization 0.32B 56% F 63% D

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.